Evidence map›Paper›PMID 25343820›Full record

ReviewNephron. Clinical practice2014

Progression from acute kidney injury to chronic kidney disease: clinical and experimental insights and queries.

Richard A Zager

Abstract readReview
In one paragraph

Review in Nephron. Clinical practice, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Postoperative rhabdomyolysis following otoplasty: an autopsy case report.Forensic science, medicine, and pathology · 2024
    Article
  3. Article
  4. Observational
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Richard A ZagerDepartment of Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle, Wash., USA.

Funding

Acute Renal Failure: Mechanisms and Adaptive ResponsesR37DK038432 · NIDDK · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ZAGER, RICHARD A. · 2002 to 2011
$3.9M
SEPSIS INDUCED ACUTE RENAL FAILURER01DK038432 · NIDDK · UNIVERSITY OF WASHINGTON · PI ZAGER, RICHARD A. · 1988 to 2015
$2.1M
Iron Therapy in Renal Disease: Potential ToxicitiesR01DK068520 · NIDDK · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ZAGER, RICHARD A. · 2004 to 2008
$1.8M
Acute Renal Failure: An Endotoxin Hyper-Responsive StateR01DK083310 · NIDDK · UNIVERSITY OF WASHINGTON · PI BOMSZTYK, KAROL, ZAGER, RICHARD A. · 2010 to 2013
$1.5M
NIDDK NIH HHS DK38432NIDDK NIH HHS DK68520NIDDK NIH HHS R01 DK038432NIDDK NIH HHS R01 DK083310NIDDK NIH HHS R37 DK038432
6 · The paper itself

Abstract

There is an increasing number of clinical studies suggesting that acute kidney injury (AKI) can be complicated by the onset of progressive renal disease. Indeed, given the frequency of AKI in hospitalized patients, it could potentially be a leading cause of, or contributor to, end-stage renal disease. Insights into the natural history of AKI and potential mechanisms for disease progression can be gleaned from experimental studies. Although such studies underscore the principle that AKI can 'heal with defects', whether ongoing renal disease develops remains a subject of debate. Indeed, in the aftermath of AKI, a variety of secondary renal protective pathways are activated, which may retard or prevent severe chronic kidney disease. Furthermore, the onset of acute uremia per se may exert surprisingly potent renal protective effects. The purpose of this brief report is to review some of the clinical and experimental data that deal with these complex issues.

Indexed as

Acute Kidney InjuryAnimalsAnti-Inflammatory AgentsBlood Urea NitrogenDisease Models, AnimalDisease ProgressionEndothelin-1GlucocorticoidsHumansKidneyNephritis, InterstitialRenal Insufficiency, ChronicRenal Replacement TherapyReperfusion InjuryUremiaAnti-Inflammatory AgentsEndothelin-1Glucocorticoids

Identifiers

PMID25343820
PMCPMC4209442

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.